134 related articles for article (PubMed ID: 36531763)
21. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
Uncini A; Vallat JM; Jacobs BC
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1105-1110. PubMed ID: 32855289
[TBL] [Abstract][Full Text] [Related]
22. Association of Guillain-Barre Syndrome With COVID-19: A Case Report and Literature Review.
Singh R; Shiza ST; Saadat R; Dawe M; Rehman U
Cureus; 2021 Mar; 13(3):e13828. PubMed ID: 33854850
[TBL] [Abstract][Full Text] [Related]
23. Guillain-Barré Syndrome in an Elderly Patient as a Complication of COVID-19 Infection.
Miyajan KF; Alyamani NA; Zafer DO; Tawakul AA
Cureus; 2021 Oct; 13(10):e19154. PubMed ID: 34868787
[TBL] [Abstract][Full Text] [Related]
24. Post-Infectious Guillain-Barré Syndrome Related to SARS-CoV-2 Infection: A Systematic Review.
Sansone P; Giaccari LG; Aurilio C; Coppolino F; Esposito V; Fiore M; Paladini A; Passavanti MB; Pota V; Pace MC
Life (Basel); 2021 Feb; 11(2):. PubMed ID: 33670000
[No Abstract] [Full Text] [Related]
25. Guillain-Barré syndrome after SARS-CoV-2 infection.
Kajita M; Sato M; Iizuka Y; Mashimo Y; Furuta N; Kakizaki S
J Gen Fam Med; 2022 Jan; 23(1):47-49. PubMed ID: 34518789
[TBL] [Abstract][Full Text] [Related]
26. Axonal-Variant Guillian-Barre Syndrome Temporally Associated With mRNA-Based Moderna SARS-CoV-2 Vaccine.
Dalwadi V; Hancock D; Ballout AA; Geraci A
Cureus; 2021 Sep; 13(9):e18291. PubMed ID: 34722067
[TBL] [Abstract][Full Text] [Related]
27. [The first Hungarian patient with Guillain-Barre syndrome after COVID-19].
Al-Muhanna N; Béres-Molnár AK; Jarecsny T; Folyovich A
Ideggyogy Sz; 2021 Jan; 74(1-2):64-66. PubMed ID: 33497053
[TBL] [Abstract][Full Text] [Related]
28. Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review.
Agosti E; Giorgianni A; D'Amore F; Vinacci G; Balbi S; Locatelli D
Neurol Sci; 2021 Feb; 42(2):607-612. PubMed ID: 32643136
[TBL] [Abstract][Full Text] [Related]
29. Guillain Barre Syndrome following delivery in a pregnant woman infected with SARS-CoV-2.
Tekin AB; Zanapalioglu U; Gulmez S; Akarsu I; Yassa M; Tug N
J Clin Neurosci; 2021 Apr; 86():190-192. PubMed ID: 33775326
[TBL] [Abstract][Full Text] [Related]
30. [Urodynamic AUR in Guillain-Barré syndrome post-infection by coronavirus Sars-CoV-2. A bibliographic review.].
Méndez-Rubio S; Laso-Martín S; Jerez-Izquierdo T; Lorenzo-García C; López-Pérez E; Vives-Dilme R; Fernández-Hernández L; Méndez-Cea B; Moreno-Sierra J; Virseda-Chamorro M; Salinas-Casado J
Arch Esp Urol; 2022 Jan; 75(1):7-18. PubMed ID: 35173070
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2-Associated Guillain-Barre Syndrome Obscured by Diabetes Mellitus Peripheral Neuropathy.
Brown M; Petrassi A; Bureau BL; Khan N; Jha P
Cureus; 2021 Mar; 13(3):e14209. PubMed ID: 33948399
[TBL] [Abstract][Full Text] [Related]
32. Childhood Guillain-Barre syndrome in the SARS-CoV-2 era: Is there any causative relation?
Pourbakhtyaran E; Heidari M; Akbari MG; Mohammadi M; Badv RS; Zamani G; Tavasoli AR; Rezaei Z; Mamishi S; Haji Esmaeil Memar E; Hosseiny SMM; Ghabeli H; Haghighi R; Ashrafi MR
Clin Case Rep; 2022 Dec; 10(12):e6772. PubMed ID: 36545550
[TBL] [Abstract][Full Text] [Related]
33. Late-Onset Guillain-Barré Syndrome and Right Facial Nerve Palsy after COVID-19 Infection.
Taguchi M; Bonner K; Memon AB
Case Rep Neurol; 2022; 14(1):12-18. PubMed ID: 35111031
[TBL] [Abstract][Full Text] [Related]
34. The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit.
Diaz P; Leveque M; Hautecloque G; Sellal F; Augereau O; Lita L; Biegle E; Belilita L; Bouterra C; Rerat P; Alvarez-Gonzalez A; Martinot M; Gerber V
J Neuroimmunol; 2022 May; 366():577842. PubMed ID: 35339941
[TBL] [Abstract][Full Text] [Related]
35. Guillain-Barré syndrome associated with SARS-CoV-2 infection: A case report with long term follow up.
Papri N; Hayat S; Mohammed A; Afsar MNA; Hasan I; Rahman A; Jahan I; Islam Z
J Neuroimmunol; 2021 Jul; 356():577590. PubMed ID: 33957540
[TBL] [Abstract][Full Text] [Related]
36. Guillain-Barré Syndrome Associated with SARS-CoV-2 in Two Pediatric Patients.
Al Amrani F; Al-Abdwani R; Al Rashdi F; Al-Ajmi E; Al Futaisi A
Sultan Qaboos Univ Med J; 2023 Aug; 23(3):400-404. PubMed ID: 37655082
[TBL] [Abstract][Full Text] [Related]
37. First Report of SARS-CoV-2 Detection in Cerebrospinal Fluid in a Child With Guillain-Barré Syndrome.
Araújo NM; Ferreira LC; Dantas DP; Silva DS; Dos Santos CA; Cipolotti R; Martins-Filho PR
Pediatr Infect Dis J; 2021 Jul; 40(7):e274-e276. PubMed ID: 33990525
[TBL] [Abstract][Full Text] [Related]
38. [Bifacial weakness with paresthesia – a rare Guillain–Barré syndrome subtype associated with SARS-CoV-2 infection].
Gaál T; Szeszák G; Torák G; Salacz P
Orv Hetil; 2021 Nov; 162(45):1803-1807. PubMed ID: 34747359
[TBL] [Abstract][Full Text] [Related]
39. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN.
Tutar NK; Eyigürbüz T; Yildirim Z; Kale N
Ideggyogy Sz; 2021 Jul; 74(7-08):286-288. PubMed ID: 34370408
[TBL] [Abstract][Full Text] [Related]
40. COVID-19-induced Guillain-Barre Syndrome: A Rare Complication of SARS-CoV-2 Infection.
Hanif M; Khan AW; Khan MA; Sundas F; Khan SJ
J Coll Physicians Surg Pak; 2021 Jul; 31(7):S123-S124. PubMed ID: 34271810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
